Market Place
Sourcing Support
Vanqua Bio to Present at AD/PD™ 2025 Conference
27 Mar 2025 //
GLOBENEWSWIRE
Vanqua Bio Presents Pre-Clinical Data on VQ-201 Antagonist
05 Dec 2024 //
GLOBENEWSWIRE
Vanqua Bio Announces Positive Phase 1 Results For VQ-101
09 Oct 2024 //
GLOBENEWSWIRE
Vanqua Bio to Participate in Upcoming Scientific Conferences
18 Sep 2024 //
GLOBENEWSWIRE
Vanqua Bio to Present at Inaugural GBA1 2024 Meeting
20 Jun 2024 //
GLOBENEWSWIRE
Vanqua Bio Starts Phase 1 Parkinson`s Trial Evaluating VQ-101
09 Apr 2024 //
GLOBENEWSWIRE
Vanqua Bio to Present at the Stifel 2024 CNS Days Conference
13 Mar 2024 //
GLOBENEWSWIRE
Vanqua Bio to Present Pre-Clinical Data on VQ-101
27 Feb 2024 //
GLOBENEWSWIRE
Vanqua Bio Advances Clinical Candidate for Parkinson™s Disease
12 Dec 2023 //
GLOBENEWSWIRE
Vanqua to Participate in the Leerink Partners Biopharma Private Company Connect
18 Oct 2023 //
GLOBENEWSWIRE
Vanqua Bio to Present at the Stifel 2023 CNS Day Conference
22 Mar 2023 //
GLOBENEWSWIRE
Vanqua Bio to Present at the Stifel 2022 CNS Day Conference
24 Mar 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.